Skip to main content
TipRanks
Go Ultimate75% OFF

PMV Pharmaceuticals (PMVP) Ratios

181 Followers

PMV Pharmaceuticals Ratios

PMVP's free cash flow for Q3 2026 was $-18.18M. For the 2026 fiscal year, PMVP's free cash flow was increased by $0.00 and operating cash flow was $-18.18M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio10.0912.2214.7822.8024.66
Quick Ratio10.0912.2214.7822.8024.66
Cash Ratio3.332.842.6910.0014.11
Solvency Ratio-6.55-3.79-2.56-2.99-2.46
Operating Cash Flow Ratio-6.45-3.57-3.97-5.89-3.81
Short-Term Operating Cash Flow Coverage0.00-145.690.000.000.00
Net Current Asset Value$ 103.38M$ 160.45M$ 180.95M$ 222.73M$ 278.28M
Leverage Ratios
Debt-to-Assets Ratio0.010.010.050.050.03
Debt-to-Equity Ratio0.010.010.060.060.04
Debt-to-Capital Ratio0.010.010.060.050.04
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.111.091.121.101.07
Debt Service Coverage Ratio0.00-163.540.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.010.000.000.000.00
Interest Debt Per Share0.020.020.280.310.25
Net Debt to EBITDA0.470.540.361.302.85
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT97.28%78.48%100.00%99.99%100.04%
EBT Per EBIT92.70%87.55%86.06%95.18%99.19%
Return on Assets (ROA)-66.70%-30.69%-27.35%-27.12%-17.45%
Return on Equity (ROE)-74.24%-33.34%-30.56%-29.80%-18.75%
Return on Capital Employed (ROCE)-81.99%-48.30%-33.65%-29.69%-18.25%
Return on Invested Capital (ROIC)-79.45%-37.83%-33.53%-29.63%-18.23%
Return on Tangible Assets-66.70%-30.69%-27.35%-27.12%-17.45%
Earnings Yield-118.37%-75.38%-46.33%-18.48%-5.55%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.000.170.390.220.40
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle0.00-2099.07-939.94-1682.37-908.65
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.002099.07939.941682.37908.65
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.40-0.99-1.16-1.40-1.03
Free Cash Flow Per Share-1.40-1.01-1.18-1.57-1.06
Dividend Paid and CapEx Coverage Ratio-2537.14-78.29-57.86-7.99-34.52
Capital Expenditure Coverage Ratio-2537.14-78.29-57.86-7.99-34.52
Operating Cash Flow Coverage Ratio-87.80-43.09-4.19-4.56-4.16
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-112.07%-66.69%-38.04%-18.09%-4.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.84-1.33-2.16-5.41-18.03
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio0.630.440.661.613.38
Price-to-Free Cash Flow (P/FCF) Ratio-0.89-1.50-2.63-5.53-21.76
Price-to-Operating Cash Flow Ratio-0.89-1.52-2.67-6.22-22.39
Price-to-Earnings Growth (PEG) Ratio-0.030.060.20-0.210.39
Enterprise Value Multiple-0.36-0.52-1.84-4.16-15.59
Enterprise Value28.53M38.20M124.42M302.35M881.41M
EV to EBITDA-0.36-0.52-1.84-4.16-15.59
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-0.39-0.74-2.20-4.21-18.39
EV to Operating Cash Flow-0.39-0.74-2.24-4.74-18.93
Tangible Book Value Per Share1.993.414.705.406.84
Shareholders’ Equity Per Share1.993.414.705.406.84
Tax and Other Ratios
Effective Tax Rate0.030.22-0.000.00-0.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-1.48-1.14-1.44-1.61-1.28
Tax Burden0.970.781.001.001.00
Interest Burden1.001.001.001.001.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.950.870.810.870.81

Currency in USD